Media Coverage Taking a New Approach to Tackle Neurodegenerative Diseases October 5, 2022 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix Awarded $2.49M from NIH to Further Support Clinical Development of Tau-Targeting Alzheimer’s Disease Therapy Candidate OLX-07010Next →Oligomerix Presents Data from IND-Enabling Studies on Clinical Candidate at Clinical Trials on Alzheimer’s Disease (CTAD) and Neuroscience 2022 Meetings
